Baptist MD Anderson Cancer Center ( Site 0013) — Jacksonville, Florida

Public research footprint of Baptist MD Anderson Cancer Center ( Site 0013), compiled from the ClinicalTrials.gov public registry.

156

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Recurrent Neck Squamous Cell Carcinoma of Unknown Primary · Stage II Breast Cancer AJCC v6 and v7 · Triple-Negative Breast Carcinoma

Recently updated registry entries

NCT05812807 — Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a… (Recruiting)
NCT04267848 — Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy… (Recruiting)
NCT02194738 — Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Baptist MD Anderson Cancer Center ( Site 0013)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.